What The Document Says

Daraxonrasib treatment causes inhibition of the KRAS protein, which leads to tumor shrinkage in pancreatic cancer patients

Best-supported causal claim extracted from Nytimes Kras PDF.

Evidence Map

How the claim is supported

Prometheus organized 360 extracted causal statements from Nytimes Kras PDF into 19 evidence regions. The lists below show where support concentrates and which relation words dominate. Audit signals report cross-context consistency checks; they are not additional document claims.

Extracted claims360from 1 source record
Evidence regions19topic clusters supporting the claim map
Context warnings718 translation checks
Agreement warnings018 overlap checks

Evidence Regions

Topic clusters with the most supporting statements

Each row is a topic-like evidence region; the count is how many extracted statements landed there.

1breakthrough in pancreatic cancer treatment42claims
2breakthrough in cancer drug development39claims
3daraxonrasib targeting kras protein36claims
4daraxonrasib extends pancreatic cancer survival35claims
5metastatic pancreatic cancer treatment32claims
6molecular screening for kras binding30claims
7challenges targeting kras protein29claims

Relation Mix

Relation words used across extracted claims

Each row counts a relation phrase, not a separate conclusion.

1leads to146uses
2increases86uses
3reduces61uses
4influences33uses
5causes27uses
6affects7uses

Artifacts

Open the view you need